La Porte, IN, United States of America

Martin Chavez

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Illinois. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Chavez. Retrieved from https://idiyas.com/inventor/martin-chavez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Martin Chavez: Innovator in Antimicrobial Treatments

Introduction

Martin Chavez is a notable inventor based in LaPorte, Indiana, who has made significant contributions to the field of antimicrobial treatments. With a total of two patents to his name, Chavez has focused his research on developing small molecules that target gram-negative bacteria, which are known for their resistance to many conventional antibiotics.

Latest Patents

Chavez's latest patents include innovative compounds that accumulate in gram-negative bacteria. These compounds are designed to enhance the effectiveness of antimicrobial treatments. The disclosed methods of treatment utilizing these compounds represent a promising advancement in combating bacterial infections that are difficult to treat.

Career Highlights

Chavez is affiliated with the University of Illinois, where he conducts his research and development work. His academic background and ongoing research efforts have positioned him as a key figure in the fight against antibiotic-resistant bacteria.

Collaborations

Chavez has collaborated with esteemed colleagues such as Paul Joseph Hergenrother and Michelle Richter. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of antimicrobial research.

Conclusion

Martin Chavez's work in developing small molecules active against gram-negative bacteria showcases his commitment to addressing critical health challenges. His contributions to antimicrobial treatments are paving the way for future innovations in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…